- Efficacy and safety of nimotuzumab plus radiotherapy for elderly patients with locally advanced cervical squamous cell carcinomaQu, A.; Wang, J.; Zhuo, Y.; Liu, Z.; Zhu, H.; Wei, L.; Sun, X.; Gao, Y.; Cheng, H.; Zhao, F.; Song, Y.; Wen, Q. L.; Zhou, X.; Wang, P.; Yang, J.; Zou, L.; Yuan, X.; Wu, D.; He, J.; Zhang, Y.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 2023-10-20 To 2023-10-24.
- Nimotuzumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma (NPC): A prospective, randomized-controlled, double-blinded, multicenter phase III clinical trial.Sun, Yan; Hu, Chaosu; Lin, Qin; Gao, Li; Wang, Jianhua; Zhu, Xiaodong; Hao, Junfang; Lang, Jin Yi; Wang, Peiguo; Ye, Ming; Li, Xia; Xu, Benhua; Wu, Rong; Bai, Chunmei; You, Qingshan; Chen, Xiaozhong; Wang, Jun; Hu, Desheng; Wu, Gang; Pan, Jian-JiAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2022-06-03 To 2022-06-07.被引 4
- Nimotuzumab combined with gemcitabine versus gemcitabine in K-RAS wild-type locally advanced or metastatic pancreatic cancer: A prospective, randomized-controlled, double-blinded, multicenter, and phase III clinical trial.Qin, Shukui; Bai, Yuxian; Wang, Zishu; Chen, Zhendong; Xu, Ruihua; Xu, Jianming; Zhang, Hongmei; Chen, Jia; Yuan, Ying; Liu, Tianshu; Yang, Lin; Zhong, Haijun; Chen, Donghui; Shen, Lin; Hao, Chunyi; Fu, Deliang; Cheng, Ying; Yang, Jianwei; Bai, Xian Hong; Li, JinAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2022-06-03 To 2022-06-07.被引 12
会议论文
Nimotuzumab combined with concurrent chemo-radiotherapy in patients with locally advanced cervical squamous cell carcinoma: A randomized, controlled, open-label, multicenter study
4阅读
